SYRE R&D Expenses
Spyre Therapeutics Inc · R&D Expenses
SYRE R&D Expenses
Latest reported$65.50Mperiod ending
SYRE Quarterly R&D Expenses ($533.00K → $65.50M)
Quarterly R&D Expenses
High-resolution chart · PNG
SYRE r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 65,503,000 | |
| 60,411,000 | |
| 44,638,000 | |
| 45,247,000 | |
| 40,145,000 | |
| 41,623,000 | |
| 50,482,000 | |
| 44,744,000 | |
| 32,636,000 | |
| 34,928,000 | |
| 33,682,000 | |
| 24,660,000 | |
| 17,386,000 | |
| 13,776,000 | |
| 14,251,000 | |
| 11,977,000 | |
| 15,373,000 | |
| 16,978,000 | |
| 16,782,000 | |
| 14,853,000 | |
| 13,579,000 | |
| 11,855,000 | |
| 15,756,000 | |
| 12,451,000 | |
| 16,869,000 | |
| 14,562,000 | |
| 17,566,000 | |
| 17,839,000 | |
| 14,806,000 | |
| 14,389,000 | |
| 11,798,000 | |
| 8,929,000 | |
| 9,122,000 | |
| 6,870,000 | |
| 5,791,000 | |
| 6,239,000 | |
| 5,835,000 | |
| 4,949,000 | |
| 4,741,000 | |
| 5,385,000 | |
| 4,420,000 | |
| 3,596,000 | |
| 3,966,000 | |
| 3,129,000 | |
| 2,736,000 | |
| 1,622,000 | |
| 2,553,000 | |
| 2,487,000 | |
| 1,257,000 | |
| 533,000 |